All News
ACR22 Will Present New Recommendations for Integrative Approach to RA Treatment
d
ACR
On Sunday Nov. 13, 2022, at ACR Convergence 2022 meeting, the ACR will present a new guideline for Exercise, Rehabilitation, Diet and Additional Integrative Interventions for Rheumatoid Arthritis.
Read Article
Video Telehealth Willingness Increased During Pandemic
Americans’ willingness to use video telehealth has increased since the beginning of the COVID-19 pandemic, rising most sharply among Black Americans and people with less education, according to a new RAND Corporation study.
Read Article
QD Clinic - 1st Line Anakinra
New-onset systemic JIA - how will you treat? #ACR22
https://t.co/cxG6ZcBXUv https://t.co/YCXD4z9BQ7
Links:
Dr. John Cush RheumNow ( View Tweet)
Video Telehealth Willingness Increased During Pandemic
Americans’ willingness to use video telehealth has increased since the beginning of the pandemic, rising most sharply among Black Americans and people with less education, according to a new study.
https://t.co/oi3C2A7yJt https://t.co/H8AhiXeU3r
Links:
Dr. John Cush RheumNow ( View Tweet)
#ACR22 Will Present New Recommendations for Integrative Approach to RA Treatment
https://t.co/FI5k6LIKrO https://t.co/I0F1wJNBDc
Links:
Dr. John Cush RheumNow ( View Tweet)
Plaquenil (HCQ) reduces #SLE mortality. Metanalysis (21 studies, 26,037 pts). Pooled findings - HCQ significantly reduced SLE mortality (HR 0.46); HCQ also reduced mortality in SLE pts w/ renal (HR=0.43), & cardiopulmonary dz (HR=0.37) https://t.co/fsHaN8wR17 https://t.co/MW8cvavzBC
Links:
Dr. John Cush RheumNow ( View Tweet)
Opportunistic Infections with JAK inhibitors in RA
Winthrop and colleagues have reviewed the occurrence of OIs associated with the use of JAK inhibitors in patients with RA, showing that Herpez zoster (HZ) was the most common OI reported.
https://t.co/CtFcnHiWKS https://t.co/qKU51vLxaP
Links:
Dr. John Cush RheumNow ( View Tweet)
We're excited to have Dr. Aurelia Najm back as an #ACR22 RheumNow reporter!
"I look forward to learning about developments in the field and finally meet with colleagues and collaborators from all over the world. "
-Dr. Najm
Follow @AurelieRheumo for real time #ACR22 coverage! https://t.co/o6Mhobt2BR
Dr. John Cush RheumNow ( View Tweet)
Dr. Robert Chao is back as a RheumNow reporter for a third year.
"I’m looking forward to the exciting hybrid format of both in person and virtual meeting this year! "
Follow @doctorRBC for real-time #ACR22 coverage! https://t.co/j6FNra7aZq
Dr. John Cush RheumNow ( View Tweet)
Join Dr. Jack Cush and Dr. Arthur Kavanaugh as they discuss, dissect and deliberate about data presented at the #ACR22 meeting in Philadelphia.
https://t.co/STvWZMS7xS https://t.co/oQt3ZMyjEN
Links:
Dr. John Cush RheumNow ( View Tweet)
QD Clinic - Seropositive Arthralgia (abstract #1604)
42 yr old woman with +RF and Arthralgias only. How to treat?
https://t.co/MgPFHa0CAd https://t.co/Aqlrc6rOSt
Links:
Dr. John Cush RheumNow ( View Tweet)
2022 EULAR Recommendations for Screening and Prophylaxis of Chronic and Opportunistic Infections
A EULAR Task force has developed recommendations for screening and prophylaxis of chronic and opportunistic infections in patients with AIIRD.
https://t.co/VrdNggfMfG https://t.co/WARs0YJLZs
Links:
Dr. John Cush RheumNow ( View Tweet)
12 pts w/ new onset IgA vasculitis (IgAV) post COVID- 19 vaccination (5F; age 52 yrs) - 10 had mRNA & 2 viral vector Vax. Time from Vax to Sxs=11.5 d; 8/12 had vasculitis w/ 1st dose; all skin (7 Jts, 4GI, 2 renal). All Rx w/ steroids https://t.co/eCcUkGeAwV https://t.co/VU1LwFxITC
Links:
Dr. John Cush RheumNow ( View Tweet)
Cluster analysis of 112 SLE pts looked at Erosive arthritis. Arthritis seen in 73%, arthralgia in 27%, erosive arthritis in 26%. Cluster that included erosive Dz also seen w/ CNS EL, serositis, Pos tests for ACPA, Carp, Sm, RNP, Dkk1 https://t.co/c7SLmFtweu https://t.co/qt9FdA1SBa
Links:
Dr. John Cush RheumNow ( View Tweet)
NY Times reports preprint article showing that taking Paxlovid w/in 5 days of COVID Test+ lowers risk of Long COVID Sxs by 26%. EMR study of 56,340 COVID pts w/ >= risk factor for severe infx; 9,217 Rx w/ Paxlovid had lesss post-Covid Sxs > 90D https://t.co/JyWEoJbUc7 https://t.co/xvTVNugwhJ
Links:
Dr. John Cush RheumNow ( View Tweet)
Final countdown! We can't wait to see you in-person! #ACR22 https://t.co/nzf0mZJyxJ
Dr. John Cush RheumNow ( View Tweet)
Deprescribing in Older Adults w/ Rheumatic dz - When Less May Be More! Polypharmacy & multimorbidity are major problems in elderly. Deprescribing identifys problematic meds & tapering, stopping, D/C or withdrawing to maximize wellness https://t.co/vMTlp7SJjI https://t.co/sYkrjcouHM
Links:
Dr. John Cush RheumNow ( View Tweet)
Swedish study of Inflammatory bowel disease (IBD) pts w/ colorectal bx show that histological (aHR: 1.42 - 2.37) & clinical activity in IBD, especially UC (Not Crohns), were risk factors for preterm birth https://t.co/blGOjGxq70 https://t.co/xVvByFN2z1
Links:
Dr. John Cush RheumNow ( View Tweet)
Hear what KOLs are saying about #ACR22. We are featuring Drs: Michele Petri, Peter Nash, Artie Kavanaugh, Jack Cush. Follow us on Twitter and head to https://t.co/V10S4oVFsv for real-time coverage. https://t.co/u4GKfCYeTK
Links:
Dr. John Cush RheumNow ( View Tweet)
The spike protein of SARS-CoV-2 drives NLRP3 inflammasome activation (one of several reasons that patient may flare or activate after COVID-19 infection or vaccination?) https://t.co/92Z14bYaUD https://t.co/iEUSgPghtT
Dr. John Cush RheumNow ( View Tweet)
